American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Publishing; 2013.
2.
CoskunM, KarakacS, KircelliF, MukaddesNM: Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder. J Child Adolesc Psychopharmacol, 19:203–206, 2009.
3.
GabrielsRL, CuccaroML, HillDE, IversBJ, GoldsonE: Repetitive behaviors in autism: Relationships with associated clinical features. Res Dev Disabil, 26:169–181, 2005.
4.
HarropC: Evidence-based, parent-mediated interventions for young children with autism spectrum disorder: The case of restricted and repetitive behaviors. Autism, 19:662–672, 2015.
5.
HollanderE, PhillipsA, ChaplinW, ZagurskyK, NovotnyS, WassermanS, IyangerR: A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30:582–589, 2004.
6.
HollanderE, SooryaL, WassermanS, EspositoK, ChaplinW, AnagnostouE: Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol, 9:209–213, 2006.
7.
MarcusRN, OwenR, KamenL, ManosG, McQuadeRD, CarsonWH, AmanMG: A placebo controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry, 48:1110–1119, 2009.
8.
MasiG, PfannerC, MillepiediS, BerloffaS: Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder. J Clin Psychopharmacol, 30:688–693, 2010.
9.
McDougleC, KreschL, PoseyD: Repetitive thoughts and behaviour in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors. J Autism Dev Disord, 30:427–435, 2000.
10.
NguyenM, MurphyT: Mirtazapine for excessive masturbation in an adolescent with autism. J Am Acad Child Adolesc Psychiatry, 40:868–869, 2001.
11.
OwenR, SikichL, MarcusRN, Corey-LisleP, ManosG, McQuadeRD, CarsonWH, FindlingRL: Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124:1533–1540, 2009.
12.
PoseyDJ, GueninKD, KohnAE, SwiezyNB, McDougleCJ: A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. J Child Adolesc Psychopharmacol, 11:267–277, 2001.
13.
RichlerJ, BishopSL, KleinkeJR, LordC: Restricted and repetitive behaviors in young children with autism spectrum disorders. J Autism Dev Disord, 37:73–85, 2007.
14.
SertdemirM, AkçaÖF: Effectiveness of low-dose aripiprazole monotherapy in the treatment for an adolescent with obsessive-compulsive disorder. Clin Neuropharmacol, 40:236–237, 2017.
15.
SooryaL, KiarashiJ, HollanderE: Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am, 17:753–771, 2008.
16.
StiglerKA, DienerJT, KohnAE, LiL, EricksonCA, PoseyDJ, McDougleCJ: Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: A 14-week, prospective, open-label study. J Child Adoles Psychopharmacol, 19:265–274, 2009.
17.
StimmelGL, DopheideJA, StahlSM: Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy, 17:10–21, 1997.
18.
ZandtF, PriorM, KyriosM: Similarities and differences between children and adolescents with autism spectrum disorder and those with obsessive compulsive disorder executive functioning and repetitive behaviour. Autism, 13:43–57, 2009.
